The Trump administration didn’t get very far with healthcare reform; the ACA was neither repealed nor replaced. But former CMS Administrator Seema Verma made a run at revamping Medicaid by using Section 1115 waivers to add working requirements. Now the Biden administration is taking steps to stop the requirements before they get started.
The Trump administration didn’t get very far with healthcare reform; the ACA was neither repealed nor replaced. But former CMS Administrator Seema Verma made a run at revamping Medicaid by using Section 1115 waivers to add working requirements. Now the Biden administration is taking steps to stop the requirements before they get started.
During the Trump administration, 19 states were at some stage of imposing Medicaid work requirements (eight waivers approved, seven pending, and four tied up in court).
Mid-February, the new administration sent out letters to two work-requirement states, Arkansas and New Hampshire, saying that CMS now has “serious concerns” about testing policies that might lead to loss of healthcare coverage amid the pandemic.
Verma made some eleventh hour changes to the waivers that will make it more difficult to undo them, but the Biden administration is working to dismantle those rules.
Changing Medicaid funding so states would receive block grants to run their programs was another change the Trump administration wanted to see. Tennessee has an 1115 waiver that would mean such funding for the state Medicaid’s program and, among other things, a closed formulary. But that waiver is now also in doubt.
In this second part of a two-part podcast episode, Managed Healthcare Executive's Managing Editor Peter Wehrwein spoke with CeCi Connolly and Margaret "Meg" Murray about Medicare Advantage utilization and challenges, highlighting proposed CMS payment cuts and prior authorization issues.
Listen
2024 Emerging Leaders in Healthcare — Submit For a Chance to Be Featured in MHE's August Issue
March 26th 2024MHE Editors are seeking diverse healthcare professionals from different backgrounds and healthcare sectors, with individual interests. Eligible candidates are early or mid-career leaders with less than 10 years of experience. Award winners will enjoy complimentary passes to the PBMI Annual National Meeting in Orlando, Florida, from Sept. 4-6. Additional perks include a feature in our August issue, a subscription to MHE and more!
Read More
In this first part of a two-part podcast episode, Managed Healthcare Executive's Managing Editor Peter Wehrwein kicks off our new podcast series "DC Roundtable," with guests Margaret "Meg" Murray, CEO of the Association of Community Affiliated Plans, and member of MHE's Editorial Advisory Board, and CeCi Connolly, president and CEO of the Alliance of Community Health Plans, for a discussion on healthcare policy issues.
Listen
What States are Doing to Regulate Pharmacy Benefit Managers
March 26th 2024In a poster presented at the 2024 American Pharmacists Association Annual Meeting and Exposition, researchers found that state-level PBM reform focused on more transparent drug pricing, better patient access to prescription drugs, and more stringent auditing and reporting requirements.
Read More
FDA Approves Combination Therapy for Pulmonary Arterial Hypertension
March 26th 2024J&J’s Opsynvi is single-tablet combination of macitentan, an endothelin receptor antagonist, and tadalafil, a PDE5 inhibitor. It will be priced on parity with Opsumit, which is also a J&J product to treat patients with PAH.
Read More